The Omicron variant is highly resistant against antibody-mediated neutralization - implications for control of the COVID-19 pandemic
M. Hoffmann, N. Krüger, S. Schulz, A. Cossmann, C. Rocha, A. Kempf, I. Nehlmeier, L. Graichen, A.-S. Moldenhauer, M. S. Winkler, M. Lier, A. Dopfer-Jablonka, H.-M. Jäck, G. Behrens, S. Pöhlmann
This study shows the Omicron variant is highly resistant to antibody neutralization, reducing effectiveness of current therapies and vaccines.
bioRxiv · Dec 12, 2021Microbiology